rct
    2012
    High Quality

    Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial

    Jones ML, Martoni CJ, Prakash S

    Published in European Journal of Clinical Nutrition

    Key Findings

    Bile salt hydrolase-active L. reuteri NCIMB 30242 reduced LDL-cholesterol by 11.6% versus placebo over 9 weeks.

    Conclusions

    Specific strain lowers LDL-C in hypercholesterolaemic adults.

    Limitations

    Industry sponsored, single strain.

    Supplements Studied

    L. reuteri NCIMB 30242 reduced LDL-cholesterol by 11.64% relative to placebo over nine weeks.

    Related Health Concerns

    High Cholesterol (Dyslipidemia)

    Study Details

    Year:2012
    Sample Size:127
    Duration:9 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.